Immunotherapy in Triple Negative Breast Cancer: Beyond Checkpoint Inhibitors

The authors highlight current data and ongoing efforts to establish the safety and efficacy of immunotherapeutic approaches beyond checkpoint inhibitors in TNBC.
[npj Breast Cancer]
Full Article
spot_img

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News